HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 53 filers reported holding HARPOON THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2 | – | 3,743 | +322.9% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 885 | -83.6% | 0.00% | – |
| Q4 2022 | $3 | -99.9% | 5,397 | -1.9% | 0.00% | – |
| Q3 2022 | $5,000 | -44.4% | 5,501 | +12.1% | 0.00% | – |
| Q2 2022 | $9,000 | +200.0% | 4,909 | +1124.2% | 0.00% | – |
| Q4 2021 | $3,000 | -96.2% | 401 | -91.7% | 0.00% | – |
| Q4 2020 | $80,000 | +263.6% | 4,845 | +271.3% | 0.00% | – |
| Q3 2020 | $22,000 | – | 1,305 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,524,425 | $66,916,000 | 29.45% |
| MPM BioImpact LLC | 3,898,422 | $57,658,000 | 20.43% |
| New Leaf Venture Partners, L.L.C. | 2,921,405 | $43,208,000 | 9.39% |
| Soleus Capital Management, L.P. | 123,200 | $1,822,000 | 1.76% |
| EcoR1 Capital, LLC | 908,547 | $13,437,000 | 1.21% |
| Orbimed Advisors | 2,446,409 | $36,182,000 | 0.52% |
| Artal Group S.A. | 850,000 | $12,572,000 | 0.49% |
| SPHERA FUNDS MANAGEMENT LTD. | 384,031 | $5,680,000 | 0.47% |
| Cormorant Asset Management, LP | 649,994 | $9,613,000 | 0.38% |
| Fosun International Ltd | 190,483 | $2,817,000 | 0.23% |